139 related articles for article (PubMed ID: 29413272)
1. Contact Radiation Therapy for Achieving Organ Preservation in Rectal Cancer After Standard Neoadjuvant Chemoradiation: Looking for a Place in the Sun.
Habr-Gama A; Perez RO
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):574-576. PubMed ID: 29413272
[No Abstract] [Full Text] [Related]
2. Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".
Kanemoto Y; Kurokawa T; Tanimoto T
Ann Surg; 2019 Dec; 270(6):e118-e119. PubMed ID: 31425284
[No Abstract] [Full Text] [Related]
3. Organ and Function Preservation in Gastrointestinal Malignancies.
Sur R; Than NW; Taggar A; Sripadam R; Sun Myint A
Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):524-532. PubMed ID: 37357120
[TBL] [Abstract][Full Text] [Related]
4. Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?".
Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; Araújo SEA; Sabbaga J; Aguilar PB; Perez RO
Ann Surg; 2019 Dec; 270(6):e119-e120. PubMed ID: 31045873
[No Abstract] [Full Text] [Related]
5. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
6. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
7. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
8. RE: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Bujko K; Rutkowski A
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27986886
[No Abstract] [Full Text] [Related]
9. Contact X-ray Brachytherapy as an Adjunct to a Watch and Wait Approach is an Affordable Alternative to Standard Surgical Management of Rectal Cancer for Patients with a Partial Clinical Response to Chemoradiotherapy.
Rao C; Stewart A; Martin AP; Collins B; Pritchard DM; Athanasiou T; Sun Myint A
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):625-633. PubMed ID: 30196845
[TBL] [Abstract][Full Text] [Related]
10. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
[TBL] [Abstract][Full Text] [Related]
11. Is organ preservation in rectal cancer ready for prime time?
Tekkis P; Tait D; Cunningham D; Brown G
Lancet; 2018 Jun; 391(10139):2480-2482. PubMed ID: 29976455
[No Abstract] [Full Text] [Related]
12. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
[TBL] [Abstract][Full Text] [Related]
13. Contact X-ray brachytherapy for rectal cancer: Past, present, and future.
Gérard JP; Barbet N; Dejean C; Montagne L; Bénézery K; Coquard R; Doyen J; Durand Labrunie J; Hannoun-Lévi JM
Cancer Radiother; 2021 Dec; 25(8):795-800. PubMed ID: 34052134
[TBL] [Abstract][Full Text] [Related]
14. [Treatment choice of locally advanced low and middle rectal cancer after neoadjuvant chemoradiation].
Wang Z; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Nov; 17(11):1068-71. PubMed ID: 25421762
[TBL] [Abstract][Full Text] [Related]
15. The role of chemoradiotherapy in organ preservation for rectal cancer.
Xie L; Chen Q; Zhu J
Ann Oncol; 2023 Apr; 34(4):440. PubMed ID: 36549588
[No Abstract] [Full Text] [Related]
16. [The value of intraluminal brachytherapy in the treatment for esophageal cancer].
Kanaev SV; Tyuryaeva EI; Levchenko EV; Dvoretsky SY; Shcherbakov AM; Avanesyan AA
Vopr Onkol; 2015; 61(1):34-9. PubMed ID: 26016143
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
[TBL] [Abstract][Full Text] [Related]
18. Total neoadjuvant therapy for rectal cancer: An emerging option.
Ludmir EB; Palta M; Willett CG; Czito BG
Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
[TBL] [Abstract][Full Text] [Related]
19. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Zeng WG; Liang JW; Wang Z; Zhang XM; Hu JJ; Hou HR; Zhou HT; Zhou ZX
Chin J Cancer; 2015 Aug; 34(10):468-74. PubMed ID: 26268466
[TBL] [Abstract][Full Text] [Related]
20. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]